title: Managing the patient with dementia in long-term care.
abstract: The majority of residents in a nursing home have some degree of dementia. The prevalence is commonly from 70% to 80% of residents. This article covers the following topics on caring for patients with dementia in long-term care: (1) the efficacy of cholinesterase inhibitors and memantine, (2) the optimal environment for maintenance of function in moderate dementia, (3) the treatment of depression and agitation, and (4) the evaluation and management of eating problems.
authors.affiliation: Division of Geriatrics, Center Communities of Brookline, Hebrew SeniorLife and Beth Israel Deaconess Medical Center, Harvard University Medical School, Boston, MA 02446, USA. jrhodeskropf@hsl.harvard.edu
authors.forename: Jennifer
authors.initials: J
authors.lastname: Rhodes-Kropf
authors.forename: Huai
authors.initials: H
authors.lastname: Cheng
authors.forename: Elizabeth Herskovits
authors.initials: EH
authors.lastname: Castillo
authors.forename: Ana Tuya
authors.initials: AT
authors.lastname: Fulton
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D003704:Dementia / Q000150:complications / Q000188:drug therapy* / Q000523:psychology; D003863:Depression / Q000150:complications / Q000523:psychology; D005260:Female; D006801:Humans; D008134:Long-Term Care; D008297:Male; D008559:Memantine / Q000627:therapeutic use*; D011595:Psychomotor Agitation / Q000150:complications / Q000523:psychology; D011788:Quality of Life; D012112:Residential Facilities; D012931:Social Environment
chemical_list: D000978:Antiparkinson Agents; D002800:Cholinesterase Inhibitors; D008559:Memantine